PANews reported on April 16 that according to CoinDesk, medical technology company Semler Scientific disclosed that it had reached a preliminary settlement agreement with the U.S. Department of Justice and would pay a fine of $29.75 million to settle allegations that the marketing of its flagship product QuantaFlo may have violated federal anti-fraud laws. As early as 2017, the company received a civil investigation request from the U.S. Department of Justice, subsequently cooperated with multiple subpoenas, and began settlement negotiations in February of this year. The investigation has nothing to do with the company's Bitcoin holdings.

In an 8-K filing with the U.S. Securities and Exchange Commission (SEC) on Tuesday, Semler Scientific revealed that it had reached an agreement with cryptocurrency exchange Coinbase to allow it to borrow cash and digital assets against its Bitcoin holdings. If the settlement agreement with the U.S. Department of Justice is approved, the company plans to "borrow money under Coinbase's master loan agreement and use the proceeds (plus cash on hand) to pay the proposed settlement amount." However, the agreement has not yet been finalized, and if a final agreement cannot be reached, the U.S. Department of Justice may still file a lawsuit, and the amount of the claim may exceed the settlement amount.